A carregar...
Hydroxyurea therapy for sickle cell anemia
INTRODUCTION: Sickle cell anemia (SCA) is a severe, inherited hemoglobin disorder affecting 100,000 persons in the US and millions worldwide. Hydroxyurea, a once daily oral medication, has emerged as the primary disease-modifying therapy for SCA. The accumulated body of evidence over 30 years demons...
Na minha lista:
| Publicado no: | Expert Opin Drug Saf |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5868345/ https://ncbi.nlm.nih.gov/pubmed/26366626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14740338.2015.1088827 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|